Medications, youth therapeutic cultures and performance consumptions: a sociological approach

"This article analyses performance consumptions among young people. The theme is explored along two main axes. The first concerns the social heterogeneity in this field, considered on two levels: the different purposes for those investments – cognitive/mental and physical performance; and the different social contexts – university and work – where performance practices and dispositions may be fostered. The second axis explores the roles of pharmacological and natural consumptions, and their interrelationship, in the dissemination of these practices. The empirical data for this analysis were drawn from an ongoing research project on performance consumptions among young people (aged 18−29 years) in Portugal, including both university students and young workers without university education. The results correspond to the stage of extensive research, for which a questionnaire was organised at a national level, using non-proportional quota sampling. On the one hand, they show that (a) there is a hierarchy of acceptance of consumptions according to their purposes, with cognitive/mental performance showing higher acceptance and (b) both pharmaceuticals and natural products are consumed for every type of performance investment. On the other, the comparison between students and workers introduces a certain heterogeneity in this general backdrop, both in terms of the purposes for their consumptions and their opting for natural or pharmacological resources. These threads of heterogeneity will prompt a discussion of the dynamics of pharmaceuticalisation within the field of performance, in particular how therapeutic cultures may be changing in terms of the way individuals relate to medications, expanding their uses in social life."

COPD: A stepwise or a hit hard approach?

Current guidelines differ slightly on the recommendations for treatment of Chronic Obstructive Pulmonary Disease (COPD) patients, and although there are some undisputed recommendations, there is still debate regarding the management of COPD. One of the hindrances to deciding which therapeutic approach to choose is late diagnosis or misdiagnosis of COPD. After a proper diagnosis is achieved and severity assessed, the choice between a stepwise or "hit hard" approach has to be made. For GOLD A patients the stepwise approach is recommended, whilst for B, C and D patients this remains debatable. Moreover, in patients for whom inhaled corticosteroids (ICS) are recommended, a step-up or "hit hard" approach with triple therapy will depend on the patient's characteristics and, for patients who are being over-treated with ICS, ICS withdrawal should be performed, in order to optimize therapy and reduce excessive medications. This paper discusses and proposes stepwise, "hit hard", step-up and ICS withdrawal therapeutic approaches for COPD patients based on their GOLD group. We conclude that all approaches have benefits, and only a careful patient selection will determine which approach is better, and which patients will benefit the most from each approach.

O papel do profissional de farmácia no conhecimento da sociedade sobre medicamentos homeopáticos

A homeopatia é uma medicina diferente da medicina tradicional, em crescente expansão pelo mundo e fundamentada por três princípios básicos defendidos por Samuel Hahnemann. A homeopatia possui diversas utilizações contudo, segundo a literatura, existe uma desconfiança em relação à sua eficácia. Os objetivos deste trabalho são, em primeiro lugar, reunir de forma organizada e objetiva todos os aspetos importantes relacionados com a homeopatia e em segundo lugar, verificar se o perfil do profissional de farmácia influencia o conhecimento da população sobre os medicamentos homeopáticos bem como estabelecer o perfil dos consumidores de medicamentos homeopáticos. Primeiramente, este trabalho consiste numa revisão que compila a diversa informação sobre homeopatia desde a sua definição, os seus princípios, evolução no mundo e introdução em Portugal, as suas utilizações, a controvérsia e o papel do profissional de farmácia no aconselhamento destes medicamentos. Numa segunda etapa, este trabalho apresenta um estudo transversal, observacional e de coorte realizado a utentes de duas farmácias em que uma delas aconselha diariamente medicamentos homeopáticos ao contrário da outra. Foi aplicado um questionário com perguntas de cariz sociodemográfico e perguntas que permitem avaliar o conhecimento dos utentes sobre esta medicina. Dos 364 indivíduos, 187 (51,4%) afirmam saber o que são medicamentos homeopáticos e destes, 113 (60,4%) possuem efetivamente conhecimento sobre homeopatia, contudo, apenas 129 (35,5%) afirmam já ter tomado estes medicamentos. Tanto o conhecimento como a toma destes medicamentos manifestam-se com maior percentagem de indivíduos na farmácia que aconselha. São os indivíduos mais jovens, com ensino superior, não casados, trabalhadores ativos e com profissão pertencente à área da saúde os que demonstram mais conhecimento sobre o tema. São as mulheres, os indivíduos com ensino superior, com profissão pertencente à área da saúde e com condição socioeconómica média os que demonstraram maior adesão a estes medicamentos. Além disto, este estudo permitiu concluir que o aconselhamento do profissional de farmácia pode ser decisivo no que respeita ao conhecimento e adesão dos utentes a este tipo de medicação. A caracterização do conhecimento e da adesão dos utentes de farmácia comunitária em relação aos medicamentos homeopáticos contribuiu para verificar que tipo de população se interessa por esta área e se a adesão a estes medicamentos é satisfatória de modo a incentivar as farmácias e os profissionais de farmácia a promoverem e aconselharem mais frequentemente medicamentos homeopáticos.

A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants

OBJECTIVE: Acute bronchiolitis is a common disorder of infants that often results in hospitalization. Apart from supportive care, no therapy has been shown to influence the course of the disease, except for a possible effect of nebulized hypertonic saline (HS). To determine whether this does have beneficial effects on length of stay in hospital or on severity scores, we undertook a double-blind, randomized, controlled trial in a pediatric department of a Portuguese hospital. METHODS: Previously healthy infants, younger than 12 months, hospitalized with mild-to-moderate acute viral bronchiolitis were randomized to receive either nebulized 3% (hypertonic, HS) or 0.9% (normal, NS) saline during their entire hospital stay. Primary endpoints were: length of hospital stay and severity scores on each day of hospitalization. Need for supplemental oxygen, further add-on medications and adverse effects were also analyzed. RESULTS: Sixty-eight patients completed the study (HS: 33; NS: 35). The median length of hospital stay did not differ between groups: HS: 5.6 ± 2.3 days; NS: 5.4 ± 2.1 days (P = 0.747). We found no difference between groups in severity scores from day 1 to day 4. There were no differences in need for supplemental oxygen or add-on medications. Patients in HS group had significantly more cough (46% vs. 20%, P = 0.025) and rhinorrhoe (58% vs. 31%, P = 0.30). CONCLUSION: This study does not support the use of nebulized HS over NS in therapy of hospitalized children with mild-to-moderate acute viral bronchiolitis